The FRIENDS anxiety treatment program: Do treatment length and additional parent resilience interventions affect child outcomes

• Conditions: Anxiety disorders; Mental Health - Anxiety

• Registration Number: ACTRN12615000265572
• Lead Sponsor: Friends Programs International

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-03-20
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

All clients attending the community clinic for group treatment will be invited to complete the research. There will be no inclusion criteria regarding levels of symptomology or a determined diagnosis. Clients may attend the clinic following GP referral, school referral or self-referral. The study intends to represent a real-world clinic to increase clinical applicability rather than a restricted university-clinic sample.

Exclusion Criteria

Participants must complete at least 50% of the intervention. Participants who are unlikely to benefit from group treatment or those likely to disrupt the treatment of others will be excluded (and offered individual psychological services). Furthermore, those at risk of harming themselves or others will be offered individual services.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anxiety levels on the Preschool Anxiety Scale and Spence Children’s Anxiety Scale[Following completion of treatment (2 weeks for the intensive group and 10 weeks for the standard group) and at 12 month follow-up]

Secondary Outcome Measures

Name	Time	Method
Resilience using the Deveruex Student Strengths Assessment and Devereux Early Childhood Assessment[Following completion of treatment (2 weeks for the intensive group and 10 weeks for the standard group) and at 12 month follow-up];Behaviour problems on the Strengths and Difficulties Questionnaire[Following completion of treatment (2 weeks for the intensive group and 10 weeks for the standard group) and at 12 month follow-up]